Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Survey Finds Majority Of Willing Japanese Patients Not Using Generics

This article was originally published in PharmAsia News

Executive Summary

According to a survey conducted by Nomura Research Institute, 51.1 percent of patients in Japan who wish to use generic drugs have not used them. Only 19 percent of surveyed have used generics and 12.4 percent expressed unwillingness to use the drugs. Among the 1,000 survey participants, 17.5 percent either have not heard of or do not know about generic drugs. Nomura noted that compared to Europe and the U.S. where more than 50 percent of patients have experience taking generic drugs, the Japanese generic drug market remains largely untapped. (Click here for more - Japanese language

You may also be interested in...



Bleach Mixtures Return To US Regulatory Radar Making COVID-19 Treatment Claims

FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.

New China Drug Regulation Legalizes Emergency Approval Mechanism

The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.

3D Carbon Partners With Resolution Medical To Produce More Than 1 Million Nasal Swabs A Week

Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.

UsernamePublicRestriction

Register

SC071276

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel